First Participant Dosed in First-in-Human Phase 1 Study of GZC8072, a Novel Ultra-Long-Acting Once-Weekly Oral Peptide GLP-1 RA BEIJING and BRIDGEWATER, Mass., Sept. 9, 2026 /PRNewswire/ — Gan&Lee Pharmaceuticals Co.,… CISION PRNewswireSeptember 9, 2026
Yuyu Pharma CEO Robert Wonsang Yu Launches "Robert's YUniverse" Podcast SEOUL, South Korea, Sept. 9, 2026 /PRNewswire/ — Robert Wonsang Yu, CEO… CISION PRNewswireSeptember 9, 2026
BankingPress ReleaseEDGE Markets Partners with Splash Sports to Bring 24/7 Banking to the $21 Million NFL Survivor Contest Powered by EDGE Connect, Splash Sports players now have access to 24/7/365… CISION PRNewswireSeptember 9, 2026
Netcracker Technology Secures Three Frost & Sullivan 2026 Honors for Excellence in OSS/BSS Innovation and Leadership Recognitions across global technology innovation, satellite OSS/BSS product leadership, and Asia-Pacific company… CISION PRNewswireSeptember 9, 2026
Press ReleaseBuilding Together: HYUNDAI-POSCO Louisiana Steel Marks a Major Milestone, Welcomes Nearly 700 Residents to Community Day $5.8 billion steel mill project marked with ceremonial event on September 4,… CISION PRNewswireSeptember 9, 2026
Press ReleaseSilicon Motion Earns ISO/SAE 21434 Automotive Cybersecurity Process Certification Certification validates that the company’s automotive cybersecurity engineering and management processes meet… CISION PRNewswireSeptember 9, 2026
Press ReleaseClinical Psychologist Urges Women to Recognise the Signs of a Dysregulated Nervous System MELBOURNE, Australia, Sept. 9, 2026 /PRNewswire/ — Women are becoming increasingly skilled… CISION PRNewswireSeptember 9, 2026
Press ReleaseMoonwalk Biosciences Announces $70 Million Series B: NYSE Content Update NYSE issues a pre-market daily advisory direct from the trading floor. NEW… CISION PRNewswireSeptember 9, 2026
